FDA Clears Glove Made from New Type of Latex

Article

The Food and Drug Administration (FDA) has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.

Traditional latex gloves are made from the milky sap of a rubber tree, Hevea braziliensis. The sap contains a protein that may trigger allergic reactions, especially after prolonged and repeated contact. Sensitized people may experience mild reactions such as skin redness, rash, hives, or itching. More severe reactions may include respiratory symptoms such as difficulty breathing, coughing spells and wheezing. Rarely, shock may occur.

Estimates vary, but anywhere from 3 percent to 22 percent of all healthcare workers are sensitized to traditional latex. Available data on the new guayule latex show that even people who are highly allergic to traditional latex do not react on first exposure to guayule latex proteins.

“This approval has the potential to make a significant difference to both the general public and the medical community at large,” said Daniel Schultz, MD, director of FDA’s Center for Devices and Radiological Health. “Gloves made from guayule latex  may prove to be a safer alternative for some people with sensitivity to traditional latex. And yet they will not sacrifice the desirable properties of traditional latex such as flexibility and strength.”

Healthcare workers first began using traditional latex gloves in the 1890s. But concerns about allergic reactions increased in the late 1980s after modifications in glove materials made them more sensitizing just as glove use was soaring in response to the HIV epidemic. Some healthcare institutions have since responded by shifting to alternative glove materials for their workers.

The FDA has taken numerous steps to address the glove allergy problem including working with industry to develop a consensus standard that identifies maximum protein and powder levels for medical gloves. A 1998 rule requires that all medical devices containing latex carry a statement on the label warning about the risk of allergic reactions (http://www.fda.gov/cdrh/dsma/fr93097.html). Because there is no data on people’s long-term experience with the Yulex glove, the product will carry a warning for now about the potential for allergic reactions.

The Yulex glove is made by the Yulex Corporation of Maricopa, Ariz.

Source: Yulex Corporation

 

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content